Skip to content
BOLUS

Signal from the log

Network Bio

50 M$ · Undisclosed · United States

Société de Palo Alto qui entraîne des modèles d'intelligence artificielle propres à une maladie, sur des tissus de patients, du sang et des données cliniques longitudinales. Elle sort de l'ombre avec une collaboration annoncée auprès d'un groupe de santé du Fortune 100.

Verified

Announced on , logged by the watch of 19 August 2026.

Operation
Funding round
Announced amount
50 M$
Stage
Undisclosed
Country
United States

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Section 32 , Thiel Bio , Founders Fund , Breyer Capital , Blue Venture Fund , JSL Health Capital

Provenance
Logged on 19 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).